Commercial collaborations and activities are central to our work at NIHR Cambridge Biomedical Research Centre and we are pleased to be working in partnership with a range of public sector and charitable partners.
Their investment in, and support for, our research is enabling us to develop our understanding of diabetes, obesity, metabolism and endocrinology in order to develop new treatments. Cambridge BRC provided over £950,000 support to the Diabetes, Obesity, Metabolism and Endocrinology theme between 2009-2010, and this helped to lever a further £7.2m investment from the following organisations:
- Diabetes UK www.diabetes.org.uk
- National Institute of Diabetes and Digestive and Kidney Diseases www2.niddk.nih.gov
- Juvenile Diabetes Research Foundation www.jdrf.org.uk
- British Heart Foundation www.bhf.org.uk
- Diabetes UK www.diabetes.org.uk
- Wellcome Trust www.wellcome.ac.uk
- University of Cambridge Department of Paediatrics www.medschl.cam.ac.uk/paediatrics
- Ipsen Fund www.ipsen-fund.org.uk
- Medical Research Council www.mrc.ac.uk
- Society for Mucopolysaccharide Disorders www.mpssociety.co.uk
- British Society for Paediatric Endocrinology and Diabetes www.bsped.org.uk
- NIHR Programme Grants for Applied Research www.nihr.ac.uk/research
- Novo Nordisk www.novonordisk.co.uk
- Protalix Biotherapeutics www.protalix.com
- Genzyme Europe BV www.genzyme.eu
- Actelion Pharmaceuticals Ltd www.actelion.com
Rightnav:
Highlights
DOME Members Receive Awards
Two members of the DOME theme, Professor Steve O'Rahilly (theme leader) and Professor Krishna Chatterjee are among the first to be awarded Wellcome Trust Senior Investigator Awards, a prestigious new scheme providing funding for exceptional researchers who demonstrate they are addressing some of the most important questions about health and disease.
Read more...
